Clinical trials: Pharmacist
Emergency Department, Clinical Pharmacist
Integrating the Clinical Pharmacists Into Emergency Department Teams
The "Emergency Department (ED) Pharmacist" is an integrated part of the ED interdisciplinary team in many countries, which have shown to improve medication safety and reduce costs related to hospitalisations.
- Trial name
- ED-PHARM (NCT04722588)
- Testing
- Introducing clinical pharmacists to the interdisciplinary ED team.
- Where
- 3 sites in Norway
- Volunteers
- 30,888 people
- Sponsor
- Hospital Pharmacy of North Norway Trust
Cardiovascular Diseases, Lung Diseases
Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases
This study will test whether enhanced continuity of pharmacy care that includes increased communication between inpatient and outpatient settings will improve the appropriateness of medication therapy and reduce the number of…
- Trial name
- IowaCOC (NCT00513903)
- Testing
- Minimal intervention, Enhanced Intervention
- Where
- United States
- Volunteers
- 954 people
- Sponsor
- University of Iowa
Prediabetes
Pharmacist-Led Continuous Glucose Monitoring for Prediabetes
The goal of this observational study is to determine if a pharmacist-led program involving continuous glucose monitoring (CGM) improves glucose control and health behavior in people with prediabetes.
- Trial name
- NCT07529366
- Testing
- Dexcom Stelo CGM
- Where
- 2 sites in United States
- Volunteers
- 40 people
- Sponsor
- University of South Florida
Hypertension
Improving Adherence to Home Blood Pressure Monitoring With Pharmacist Support
The purpose of this research study is to evaluate the impact of monitoring blood pressure from home everyday with pharmacist support.
- Trial name
- NCT04577131
- Testing
- Weekly check-in
- Where
- United States
- Volunteers
- 1 people
- Sponsor
- Virginia Commonwealth University
Hypertension
Tailored Intervention to Improve Medication Adherence in Patients With Hypertension
Patients with hypertension have an increased risk of stroke and myocardial infarction. However, poor adherence to treatment with antihypertensives and lipid-lowering agents occurs frequently within this patient group.
- Trial name
- NCT01742923
- Testing
- Complex tailored intervention, Usual care
- Where
- Denmark
- Volunteers
- 532 people
- Sponsor
- Odense University Hospital
Atrial Fibrillation
AIHEMAF - P "An Innovative Healthcare Model for AF Patients"
Non-profit observational study on the role of the community pharmacist and "the pharmacy of services" in the case management of patients suffering from atrial fibrillation and being treated with new generation oral anticoagulants
- Trial name
- AIHEMAF - P (NCT05086991)
- Testing
- Follow up
- Where
- Italy
- Volunteers
- 50 people
- Sponsor
- Farmacia La Regina s.r.l.
Opioid Use, Acute Pain
Appropriate Opioid Quantities for Acute Pain - Pharmacist Study
Prescription opioids contribute to opioid related deaths, overdose and addiction. Unused prescribed opioids are not routinely being stored or disposed of appropriately and their availability is associated with harms.
- Trial name
- NCT04484610
- Testing
- Pharmacist Practice Change to Dispense Appropriate Opioid Quantities for Acute Pain
- Where
- Canada
- Volunteers
- 205 people
- Sponsor
- Centre for Addiction and Mental Health
Osteoporosis
Physician-Pharmacist Collaboration for Osteoporotic Patient Follow-up
The purpose of this study is to evaluate the follow-up of the osteoporotic patient by a physician-pharmacist collaboration.
- Trial name
- SIOUX (NCT02892188)
- Where
- France
- Volunteers
- 120 people
- Sponsor
- Centre Hospitalier Régional Metz-Thionville
Adverse Drug Event, Potential Adverse Drug Event, and Quality Measures
Emergency Pharmacist Safety Study
The Emergency Department (ED) is a unique environment in medicine, and many safety mechanisms used in other hospital settings cannot be applied in the ED.
- Trial name
- NCT00382434
- Testing
- presence of an emergency pharmacist in the ED
- Where
- United States
- Volunteers
- 10,224 people
- Sponsor
- University of Rochester
Home Care, Pharmacists
Home Medication Reviews by Pharmacists in Ontario, Canada
RATIONALE: Several examples in the literature describe the types of medication management issues uncovered during the course of home-based medication reviews.
- Conditions
- Home Care, Pharmacists, Medication Therapy Management
- Trial name
- NCT02658604
- Testing
- Home medication review by a pharmacist
- Where
- Canada
- Volunteers
- 100 people
- Sponsor
- University of Waterloo
ALL, Adult
Optimising Pharmacist-led Medication Reviews in Primary Care
An increasing number of people are diagnosed with long-term conditions and are prescribed medicines to manage these conditions. Medication reviews (MRs) are used to optimise medicines, improve health outcomes, and decrease…
- Trial name
- OPen (NCT05928104)
- Testing
- Medication review
- Where
- 3 sites in United Kingdom
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- University of East Anglia
Diabetes Mellitus
Pharmacist-driven CGM Use in the Uninsured Population
This is a pilot study. The purpose is to (1) provide access to continuous glucose monitoring (CGM) to patients (purchased through a grant) and (2) systematically record and analyze the results of the glucose monitoring by the…
- Trial name
- NCT03477838
- Testing
- FreeStyle LibrePro CGM
- Where
- United States
- Volunteers
- 28 people
- Sponsor
- Virginia Commonwealth University
Medication Adherence, Medication Nonadherence
Collaborative Nurse-pharmacist Counseling for Self-administered Biologics
The goal of this clinical trial is to learn if nurse-pharmacist counseling can improve patient knowledge and confidence and prevent side effects in patients who start a biologic medication in-office and later continue the…
- Conditions
- Medication Adherence, Medication Nonadherence, Adverse Drug Event
- Trial name
- COLLAB (NCT05798104)
- Testing
- Collaborative nurse-pharmacist counseling
- Where
- United States
- Sponsor
- Tonia Carr
Diabetes, Chronic Kidney Disease
The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH
Cardiovascular disease (disease of the heart and blood vessels) is one of the leading causes of death in Canada. It also carries a financial burden on the Canadian economy with a yearly cost close to $21 billion divided between…
- Conditions
- Diabetes, Chronic Kidney Disease, Established Atherosclerotic Vascular Disease, Framingham Risk Score More Than 20 Percent
- Trial name
- RxEACH (NCT01979471)
- Testing
- Advanced Care
- Where
- Canada
- Volunteers
- 723 people
- Sponsor
- University of Alberta
Pharmacist-Patient Relations
The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan
This study aimed to assess the impact of the clinical pharmacist on enhancing type 2 diabetic patients outcomes in a primary health care center.
- Trial name
- NCT06029842
- Testing
- Collaborative approach of clinical pharmacist with physicians in a medical center
- Where
- Jordan
- Volunteers
- 103 people, healthy volunteers welcome
- Sponsor
- University of Jordan
AOD Prescription
Impact of Renal Function Availability to Community Pharmacist for Dispensing Direct Oral Anticoagulant in Ambulatory Patients on Bleeding Occurrence
The use of direct oral anticoagulants (AODs) in the prevention and treatment of thromboembolic diseases is increasing, with a favorable benefit/risk balance and improved quality of life for patients.
- Trial name
- Hemorrag-IR (NCT06739603)
- Testing
- pharmaceutical analysis
- Volunteers
- 1,920 people
- Sponsor
- Université de Reims Champagne-Ardenne
Type 2 Diabetes
Real-world Effects of Using Intermittently Scanned Continuous Glucose Monitoring and Pharmacist-led Coaching on the Management of Type 2 Diabetes Among Adults Not Using Insulin (REAL isCGM T2D)
The goal of this prospective study is to evaluate diabetes outcomes after initiating second generation intermittently scanned continuous glucose monitoring (isCGM) plus one pharmacist consultation session compared with capillary…
- Trial name
- REAL isCGM T2D (NCT06837103)
- Testing
- Intermittently Scanned Continuous Glucose Monitor
- Where
- Canada
- Volunteers
- 250 people
- Sponsor
- LMC Diabetes & Endocrinology Ltd.
Anticoagulants, Atrial Fibrillation
Improving Anticoagulation Control in VISN 1
Over 100,000 VHA patients receive anticoagulants (blood thinners) each year to prevent blood clots (including strokes). Too much anticoagulation increases the risk of serious or even fatal bleeding, and too little anticoagulation…
- Conditions
- Anticoagulants, Atrial Fibrillation, Venous Thromboembolism
- Trial name
- NCT01653405
- Testing
- Multifaceted behavioral intervention
- Where
- United States
- Volunteers
- 1,260,576 people
- Sponsor
- VA Office of Research and Development
Intervention Study
Intervention Study on Medication Reconciliation Among Pharmacists in Two Tertiary Hospitals in Nigeria
This study will assess the current practice of medication reconciliation among pharmacists in the selected institutions with a view to making an intervention to address gaps discovered
- Trial name
- NCT03182972
- Testing
- Medication reconciliation
- Where
- 2 sites in Nigeria
- Volunteers
- 1,000 people, healthy volunteers welcome
- Sponsor
- University of Ibadan
Drug Related Problem
The Effectiveness of Pharmaceutical Service for INPATDRP
Medication risk is defined as the potential for loss or harm that may result from the use of medications during the course of treatment.
- Trial name
- NCT06674512
- Testing
- Clinical Pharmacist-led Pharmaceutical Services
- Where
- China
- Volunteers
- 220 people
- Sponsor
- Zhejiang Provincial People's Hospital